Here's why we took a position in the iShares NASDAQ Biotechnology Index.
Not only did hedge funds as a class underperform the S&P 500 by fully 10% through May 10, but only a small sliver of funds managed to outperform it.
Yahoo will acquire massive traffic gains in this $1.1 billion deal.
"I've been all dollar, all the time."
Carter Lecraw discusses his red, white and blue investing philosophy.